FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

119361006: Plasma specimen (specimen)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
180900016 Plasma specimen en Synonym Active Entire term case insensitive SNOMED CT core module
707016010 Plasma specimen (specimen) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1220466017 Plasma sample en Synonym Active Entire term case insensitive SNOMED CT core module

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plasma specimen Is a Acellular blood (serum or plasma) specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen procedure Hematology false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Plasma true Inferred relationship Existential restriction modifier 1
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Liquid substance false Inferred relationship Existential restriction modifier
Plasma specimen Is a Body fluid specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Acellular blood false Inferred relationship Existential restriction modifier 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Mass concentration of morphine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of insulin-like growth factor-2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of growth hormone releasing hormone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of pipecolic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of EDDP methadone metabolite in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of ammonia in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of buprenorphine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of morphine metabolite in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of adipylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement component C6 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of insulin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of ascorbic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Fasting substance concentration of glucose in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of alpha-3 ganglionic acetylcholine receptor antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of neuronal paraneoplastic antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of alpha-aminoadipate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of argininosuccinate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of isopropanol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of thiopentone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement factor I in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Presence of activated protein C resistance in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of apixaban in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Phenotype of apolipoprotein E in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of gamma-aminobutyrate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of disopyramide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of hydroxyprogesterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 25-hydroxyvitamin D3 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of beta carotene in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 18-hydroxycortisol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of bile acids, total in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of vancomycin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of muscle specific tyrosine kinase antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 11-oxo-pregnanetriol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of gold in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of rheumatoid factor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of tryptophan in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of methionine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of gastric inhibitory peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of prekallikrein in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of D-dimer in plasma expressed in fibrinogen equivalent units (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of haptoglobin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of orotate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of aspartate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of salicylate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of homocitrulline in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of troponin T in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of linoleylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of 2,8-docosahexaenoic acid to creatinine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of antimyeloperoxidase antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of primidone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Percent of glycophorin count in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Plasma clinical chemistry Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of pancreatic polypeptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of guanidinoacetate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of soluble transferrin receptor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of gabapentin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of vitamin C in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of normirtazepine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of fibroblast growth factor 23 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Percent activity of alpha-2-antiplasmin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 1 receptor antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of flunitrazepam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of amiodarone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of alloisoleucine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of sucrose in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of thymidine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of von Willebrand factor inhibitor in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of 21-hydroxypregnenolone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of insulin-like growth factor-1 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of alpha-fetoprotein in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of lactose in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of unconjugated bilirubin (calculated) in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of rifampicin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of acetoacetate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of topiramate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of dihydrotestosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of vasoactive intestinal peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of temazepam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of conjugated to total bilirubin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of docosanoate (C22) in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxylinoleylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Plasma renin activity Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of methemalbumin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of cocaine and amphetamine regulated transcript peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of mirtazapine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of free protein S in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of coagulation factor X in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxypalmitoylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Qualitative result of HIV (human immunodeficiency virus) p24 antigen in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of methylphenidate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of voltage gated potassium channel antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of methaqualone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of pregnancy associated plasma protein A in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of phenytoin, free in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of procalcitonin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement 2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of androstenedione to testosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement 3d in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of aspartic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of carnitine free to total in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of beta-hydroxybutyrate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1

Start Previous Page 7 of 8 End

This concept is not in any reference sets

Back to Start